Over the last 12 months, four ProMIS Neurosciences Inc. insiders bought into shares at market prices, about $8.7 million in total, and none of them sold.
Yu Fan (Director) made the biggest buy, worth around $8.5 million.
4 quarters in a row of net buying by insiders. Insiders bought in 5 of the last 7 full quarters. 27 investment managers listed PMN in their latest 13F filings (Q2 2026); more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Kaplan Johanne | Executive Officer | Buy | 2,280 | $13.30 | $30K | SEC |
| Apr 23, 2026 | Kirwin Patrick D. | Director | Buy | 4,000 | $11.33 | $45K | SEC |
| Mar 6, 2026 | Williams Eugene | Director | Buy | 2,000 | $24.40 | $49K | SEC |
| Mar 4, 2026 | Williams Eugene | Director | Buy | 1,000 | $21.89 | $22K | SEC |
| Mar 4, 2026 | Williams Eugene | Director | Buy | 1,000 | $22.53 | $23K | SEC |
| Mar 4, 2026 | Williams Eugene | Director | Buy | 2,000 | $24.00 | $48K | SEC |
| Feb 23, 2026 | Kaplan Johanne | Executive Officer | Buy | 1,629 | $15.35 | $25K | SEC |
| Feb 5, 2026 | Yu Fan | Director | Buy | 700,741 | $12.13 | $8.5M | SEC |
| Oct 6, 2025 | Milbury Max A. | Other | Buy | 30,392 | $0.49 | $15K | SEC |
| Feb 12, 2025 | Cashman Neil | Executive Officer | Buy | 15,000 | $0.97 | $15K | SEC |
| Sep 24, 2024 | Shafmaster Madge K. | Director | Buy | 70,000 | $1.30 | $91K | SEC |
| Sep 24, 2024 | Shafmaster Madge K. | Director | Buy | 70,000 | $1.28 | $90K | SEC |
| Sep 24, 2024 | Shafmaster Madge K. | Director | Buy | 60,000 | $1.25 | $75K | SEC |
| Sep 18, 2024 | GORDON MICHAEL S | 10% Owner | Buy | 16,292 | $1.40 | $23K | SEC |
| Sep 18, 2024 | GORDON MICHAEL S | 10% Owner | Buy | 76,931 | $1.22 | $94K | SEC |
In the last 12 months ProMIS Neurosciences Inc. insiders made open-market purchases worth about $8.7 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in PMN was filed on 2026-08-07.
27 investment managers reported holding PMN in SEC Form 13F filings for Q2 2026.
No congressional trades in PMN were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).